Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Accetta

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 9, 2008
High temperature and hospitalizations for cardiovascular and respiratory causes in 12 European citiesPaola Michelozzi, Gabriele Accetta, Manuela De Sario, et al.
Heart (British Cardiac Society)|September 21, 2016
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillationA John Camm, Gabriele Accetta, Giuseppe Ambrosio, et al.
Tropical Medicine & International Health : TM & IH|April 17, 2021
Accuracy of health-related quality of life in identifying systolic dysfunction in patients with Chagas cardiomyopathyMatheus Ribeiro Ávila, Pedro Henrique Scheidt Figueiredo, Vanessa Pereira Lima, et al.
Circulation. Cardiovascular Quality and Outcomes|February 26, 2015
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial FibrillationGregory Y H Lip, Sophie K Rushton-Smith, Samuel Z Goldhaber, et al.
Plos One|October 30, 2016
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF RegistrySylvia Haas, Hugo Ten Cate, Gabriele Accetta, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 28, 2026
Biopsy RNA-seq captures TROP-2-linked migration and clonal resistance to forecast aggressiveness in metastatic melanomaMartina Betti, Celeste Accetta, Brindusa Ana Maria Arteni, et al.
Frontiers in Molecular Biosciences|March 2, 2026
Unlocking personalized endometrial cancer treatment: the critical role of the BBIRE biobank in sample collection and distributionV Bruno, M Betti, L Ciuffreda, et al.
Journal of Medicinal Chemistry|July 28, 2022
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory DiseasesLaura Carzaniga, Ian D Linney, Andrea Rizzi, et al.
Cancers|December 30, 2025
Pregnancy vs. Postpartum Breast Cancer: Distinct Tumor Biology and Survival Trends in a Contemporary CohortElena Jane Mason, Alba Di Leone, Beatrice Carnassale, et al.
Blood Advances|November 8, 2019
Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patientsMargherita Maffioli, Toni Giorgino, Barbara Mora, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
American Journal of Respiratory and Critical Care Medicine|December 9, 2008
High temperature and hospitalizations for cardiovascular and respiratory causes in 12 European citiesPaola Michelozzi, Gabriele Accetta, Manuela De Sario, et al.
Heart (British Cardiac Society)|September 21, 2016
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillationA John Camm, Gabriele Accetta, Giuseppe Ambrosio, et al.
Tropical Medicine & International Health : TM & IH|April 17, 2021
Accuracy of health-related quality of life in identifying systolic dysfunction in patients with Chagas cardiomyopathyMatheus Ribeiro Ávila, Pedro Henrique Scheidt Figueiredo, Vanessa Pereira Lima, et al.
Circulation. Cardiovascular Quality and Outcomes|February 26, 2015
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial FibrillationGregory Y H Lip, Sophie K Rushton-Smith, Samuel Z Goldhaber, et al.
Plos One|October 30, 2016
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF RegistrySylvia Haas, Hugo Ten Cate, Gabriele Accetta, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 28, 2026
Biopsy RNA-seq captures TROP-2-linked migration and clonal resistance to forecast aggressiveness in metastatic melanomaMartina Betti, Celeste Accetta, Brindusa Ana Maria Arteni, et al.
Frontiers in Molecular Biosciences|March 2, 2026
Unlocking personalized endometrial cancer treatment: the critical role of the BBIRE biobank in sample collection and distributionV Bruno, M Betti, L Ciuffreda, et al.
Journal of Medicinal Chemistry|July 28, 2022
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory DiseasesLaura Carzaniga, Ian D Linney, Andrea Rizzi, et al.
Cancers|December 30, 2025
Pregnancy vs. Postpartum Breast Cancer: Distinct Tumor Biology and Survival Trends in a Contemporary CohortElena Jane Mason, Alba Di Leone, Beatrice Carnassale, et al.
Blood Advances|November 8, 2019
Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patientsMargherita Maffioli, Toni Giorgino, Barbara Mora, et al.
Pageof 22